Summary
Osteopore Limited designs, develops, and markets bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications in Singapore, Australia, and internationally. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; and Osteomesh, a bioresorbable implant that is used in craniofacial surgery to repair various types of fractures, such as orbital floor fracture, as well as to fill surgical defects. Osteopore Limited has a collaboration agreement with Livingstone Health Holding Limited to jointly develop new applications and products for regenerating bone and tissue. The company was incorporated in 2003 and is headquartered in Singapore.
History
Osteopore was founded in 2012 by Professor Nihal Engin Vrana, an Assistant Professor at the National University of Singapore. From early on, Osteopore has focused on developing technological and products related to regenerative medicine, wound care and tissue engineering. Over the years, we have earned multiple awards and patents internationally, reinforcing our position as a leader in these fields.
Mission
Our mission at Osteopore is to enable and transform regenerative medicine through the development of technologies and products that can meet the ever-changing needs of clinicians and patients.
Vision
Our vision is to be the global leader in regenerative medicine, and to establish ourselves as a trusted partner of clinicians and patients in the pursuit of excellence in healthcare.
Key Team
Ms. Deborah Ho AGIA, B.Com. (Company Sec.)
Recognition and Awards
Osteopore has been honored with several prestigious awards including the Singapore A*STAR Innovator Award, the Global Brigadier Awards, and the European Women in Science & Technology Awards.
References
